Completed
A randomized trial of highly active antiretroviral therapy in acute/early HIV infection
Learn MoreCompleted
A Comparison of Two Ways to Manage Anti-HIV Treatment
Learn MoreCompleted
A tri-national (Canada, UK, USA) randomized, controlled trial to determine the optimal management of patients with HIV infection for whom first and second-line highly active antiretroviral therapy has failed
Learn MoreCompleted
A Pilot Study Comparing Two Modalities of Multiple Drug Rescue Therapy (MDRT) among Pre-Treated, HIV-1 Infected Individuals - Full versus Sensitivity-Based MDRT Protocol: Trial results
Learn MoreReporting
Development of a psychosocial intervention trial with the goal to improve older adults' ability to cope with HIV-Associated Neurocognitive Disorder (HAND)
Learn MoreReporting
Safety, tolerability, and effect on immune function of cannabinoids
Learn MoreCompleted
Brain imaging to understand HIV-associated neurocognitive disorder and predict response to cognitive training
Learn MoreReporting
Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
